ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Aurobindo Pharma,Crompton Greaves, Hindalco Industries

AUROBINDO PHARMA Profits on Generics Aurobindo Pharma is a major producer of bulk drugs or active pharmaceutical ingredients (API) and drug intermediates and is a leader in semi-synthetic penicillins and cephalosporins. The company, which derives almost half of its revenues through exports, has intensified its export orientation to adapt itself and capture the emerging opportunities in the changing global pharmaceutical arena.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top